| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $72.2M | -13.1% |
| SG&A Expense | $33.2M | -6.9% |
| Operating Income | -$105.4M | +11.3% |
| Interest Expense | $1.8M | +790.6% |
| Net Income | -$105.9M | +11.1% |
| EPS (Basic) | -$2.42 | +12.9% |
| EPS (Diluted) | -$2.42 | +12.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $92.6M | -51.2% |
| Current Assets | $100.0M | -49.8% |
| Total Assets | $103.9M | -49.0% |
| Current Liabilities | $13.1M | -32.3% |
| Long-term Debt | $15.0M | +0.0% |
| Total Liabilities | $28.6M | -16.8% |
| Stockholders' Equity | $75.4M | -55.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$97.2M | +0.8% |
| Capital Expenditures | $267K | -89.2% |
| Investing Cash Flow | -$267K | +89.2% |
| Financing Cash Flow | $262K | -99.1% |
| Free Cash Flow | -$97.5M | +3.0% |